Bronchiolitis Obliterans Syndrome
📧 Sign up to get email alerts when something new happens for Bronchiolitis Obliterans Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/2 study of alvelestat (MPH966), an oral neutrophil elastase inhibitor, for bronchiolitis obl…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. [Phase 2]
Phase 2 trial update for LAM-001 in lung transplant recipients with bronchiolitis obliterans syndrome and chronic lung allograft dysfunction…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) [Phase 3]
The Phase 3 extension trial BOSTON-3 evaluating liposomal cyclosporine A added to standard of care for bronchiolitis obliterans syndrome in …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts [Phase 3]
Phase 3 clinical trial update evaluating extracorporeal photopheresis for bronchiolitis obliterans syndrome in Medicare recipients of lung a…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome
A clinical trial is recruiting to evaluate clonogenic epithelial cell populations in patients with bronchiolitis obliterans syndrome.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children
This clinical trial update describes a study evaluating novel pulmonary function measures to diagnose Bronchiolitis Obliterans Syndrome afte…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
This clinical trial is evaluating plasma and radiologic biomarkers of response to extracorporeal photopheresis in lung transplant recipients…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) [Phase 2]
A Phase 2 clinical trial BEBOP evaluating belumosudil for prevention and treatment of bronchiolitis obliterans syndrome and bronchiolitis ob…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
The RV-BOS study is a clinical trial registry entry assessing how respiratory viruses affect bronchiolitis obliterans syndrome after allogen…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients
This clinical trial update indicates a National Taiwan University Hospital study recruiting hematopoietic stem cell transplant patients to l…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating nintedanib for bronchiolitis obliterans syndrome and bronchiolitis obliterans after hematopoietic stem cel…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib [Phase 2]
This clinical trial update describes a Phase 2 rollover study of Itacitinib to provide continued treatment for participants previously enrol…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant [Phase 3]
A Phase 3 clinical trial evaluating ARINA-1 to prevent progression of bronchiolitis obliterans syndrome in participants with bilateral lung …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: ex Vivo Study of Liposomes Loaded With Everolimus in Chronic Lung Allograft Disfunction
An ex vivo study investigates delivering everolimus via liposomes for chronic lung allograft dysfunction associated with Bronchiolitis Oblit…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT) [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating ruxolitinib for bronchiolitis obliterans syndrome following allogene…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant [Phase 1]
This Phase 1 trial evaluated Itacitinib for bronchiolitis obliterans syndrome after donor hematopoietic cell transplant and has been termina…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2 [Phase 3]
This document reports a completed Phase 3 trial evaluating nintedanib in lung transplant recipients with bronchiolitis obliterans syndrome.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrome [NA]
A clinical trial update on mechanisms underlying airway basal cell dysfunction in Bronchiolitis Obliterans Syndrome and the investigation of…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation
This is a completed retrospective chart review of patients with chronic lung allograft dysfunction presenting as bronchiolitis obliterans sy…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant) [NA]
A clinical trial evaluating 3D magnetic resonance spirometry and its comparison with conventional spirometry in healthy subjects and patient…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation [Phase 1, Phase 2]
Itacitinib was studied for safety and efficacy in Bronchiolitis Obliterans Syndrome after lung transplantation. The Phase 1/2 trial was term…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation
Completed clinical trial evaluating early detection and management of bronchiolitis obliterans syndrome after pediatric hematopoietic stem c…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Study of Pulmonary MRI for the Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Stem Cell Transplantation [NA]
Completed clinical trial evaluating pulmonary MRI as a diagnostic tool for bronchiolitis obliterans syndrome after allogeneic stem cell tran…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) [Phase 2]
Phase 2 safety study of liposomal cyclosporine A for bronchiolitis after hematopoietic cell transplantation was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome [Phase 2]
Phase 2 trial update on ruxolitinib for newly diagnosed bronchiolitis obliterans syndrome with hematologic malignancy.